Nicox Postpones Nasdaq Listing Due to Market Volatility

Nicox SA announced that due to the extreme volatility of the financial markets, it has decided to postpone its dual listing on Nasdaq, concluding that it would not be in the interest of their existing shareholders at this time, according to a company news release.

The purpose of a Nasdaq listing is to allow the extensive U.S. healthcare and biotech investor community better access to Nicox’s stock, and to gain equity research coverage by U.S. specialist analysts.

There was no additional information provided at this time.